Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections

Dalbavancin represents a promising treatment for cardiovascular prosthetic infections due to its prolonged half-life, bactericidal activity, large spectrum of activity, and excellent biofilm penetration. However, the use of dalbavancin in this setting is limited, and only a few cases have performed...

Descrición completa

Detalles Bibliográficos

Principais autores:	Altea Gallerani, Milo Gatti, Andrea Bedini, Stefania Casolari, Gabriella Orlando, Cinzia Puzzolante, Erica Franceschini, Marianna Menozzi, Antonella Santoro, Nicole Barp, Sara Volpi, Alessandra Soffritti, Federico Pea, Cristina Mussini, Marianna Meschiari
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-11-01
Series:	Antibiotics
Assuntos:	dalbavancin prosthetic valve endocarditis cardiac implantable electronic devices infections prosthetic vascular graft infections therapeutic drug monitoring
Acceso en liña:	https://www.mdpi.com/2079-6382/12/11/1639
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!